CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q4 FY23 results · Jan–Mar 2023
CLNINDIA reported revenue from operations of ₹179.65 crore (down 14.5% from Q4 FY22) and net profit of ₹9.23 crore (down 43.0% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 179.65 | 210.06 | −14.5% | 178.26 | +0.8% |
| Other income | 0.42 | 1.30 | −67.7% | 0.90 | −53.3% |
| Total income | 180.07 | 211.36 | −14.8% | 179.16 | +0.5% |
| Profit before tax | 12.26 | 12.45 | −1.5% | 8.58 | +42.9% |
| Net profit for the period | 9.23 | 16.20 | −43.0% | 6.72 | +37.4% |
| EPS, basic (₹) | 4.00 | 7.02 | −43.0% | 2.91 | +37.5% |
| Net margin (%) | 5.1 | 7.7 | 3.8 |
Standalone
- Filed with BSE
- 24 May 2023, 15:19 IST
- Board meeting
- 16 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE